Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia

Blood

Volumn 88, Issue 5, 1996, Pages 1568-1575

  Garcia Marco, Jose A ^a   Caldas, Carlos ^b   Price, Cathy M ^b   Wiedemann, Leanne M ^b   Ashworth, Alan ^b   Catovsky, Daniel ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RETINOBLASTOMA PROTEIN;

ARTICLE; B CELL LEUKEMIA; BREAST CARCINOMA; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CELL POPULATION; CHROMOSOME 13Q; CHROMOSOME DELETION 13; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LOCUS; HUMAN; HUMAN CELL; INTERPHASE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029794418     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1568.bloodjournal8851568     Document Type: Article

References (33)

1. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Cuneo A, Knuutila S, Elonen E, Gahrton G: Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720, 1990
2. Fitchett M, Griffiths MJ, Oscier DG, Johnson S, Seabright M: Chromosome abnormalities involving band 13q14 in hematologic malignancies. Cancer Genet Cytogenet 24:143, 1987
3. Peterson LC, Lindquist LL, Church S, Kay NE: Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: Multiple clones, subclones, and nonclonal alterations in 82 midwestern patients. Genes Chrom Cancer 4:273, 1992
4. Liu Y, Soderhall S, Juliusson G, Gahrton G, Einhorn S: Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia. Genes Chrom Cancer 4:250, 1992
5. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, Nikiforova N, Buys C, Soderhall S, Yankovsky N, Zabarovsky E, Einhorn S: 13q deletions in lymphoid malignancies. Blood 86:1911, 1995
6. Liu Y, Szekely L, Grander D, Soderhall S, Juliusson G, Gahrton G, Linder S, Einhorn S: Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: Evidence for a role of an adjacent locus. Proc Natl Acad Sci USA 90:8697, 1993
7. Chapman RM, Corcoran MM, Gardiner A, Hawtorn LA, Cowell JK, Oscier DG: Frequent homozygous deletions of the D13S25 locus in chromosome region 13q14 defines the location of a gene critical in leukaemogenesis in chronic B-cell lymphocytic leukaemia. Oncogene 9:1289, 1994
8. Devilder MC, Francois S, Bosic C, Moreau A, Mellerin MP, Le Paslier D, Bataille R, Moisan JP: Deletion cartography around the D13S25 locus in B cell chronic lymphocytic leukemia and accurate mapping of the involved tumor supressor gene. Cancer Res 55:1355, 1995
9. Newcomb EW, Thomas A, Selkirk A, Lee SY, Potmesil M: Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation. Cancer Res 55:2044, 1995
10. Brown AG, Ross FM, Dunne EM, Steel CM, Weir-Thompson EM: Evidence for a new tumor supressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 3:67, 1993
11. Hawthorn L, Roberts T, Verlind E, Kooy RF, Cowell JK: A yeast artificial chromosome contig that spans the RB1-D13S31 interval on human chromosome 13 and encompasses the frequently deleted region in B-cell chronic lymphocytic leukemia. Genomics 30:425, 1995
12. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Orminston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088, 1994
13. Schutte M, Rozenblum E, Moskaluk C, Guan X, Hoque A, Hahn S, da Costa L, de Jong P, Kern S: An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12. Cancer Res 55:4570, 1995
14. Garcia-Marco J, Jones D, Colman S, Matutes E, Oscier D, Catovsky D, Price CM: Lineage restriction of trisomy 12 and RB1 deletion in chronic lymphocytic leukemia by combined immunophenotyping and dual color interphase FISH. Blood 86:344a, 1995 (abstr, suppl 1)
15. Matutes E, Owusu-Ankomah K, Morilla R, Garcia-Marco J, Houlihan A, Que TH, Catovsky D: The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994:1640, 1994
16. ISCH (1995): Mitelman F (ed): An International System of Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
17. Anastasi J, Le Beau MM, Vardiman JW, Westbrook CA: Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe. Am J Pathol 136:131, 1990
18. Weinberg RA: Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49:3713, 1989
19. Rozman C, Montserrat E: Chronic lymphocytic leukemia. N Engl J Med 333:1052, 1995
20. Knudson AG: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437, 1985
21. Marshall CJ: Tumor suppressor genes. Cell 64:312, 1991
22. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D: Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 11:210, 1995
23. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozemblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor supressor gene at human chromosome 18q21.1. Science 271:350, 1996
24. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789, 1995
25. Stilgenbauer S, Dohner H, Bulgay-Morschel M, Weitz S, Bentz M, Lichter P: High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphocytic leukemia shown by interphase cytogenetics. Blood 81:2118, 1993
26. Stilgenbauer S, Leupolt E, OhI S, Weib G, Schroder M, Fischer K, Bentz M, Lichter P, Dohner H: Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 55:3475, 1995
27. Cleton-Jensen A-M, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, Stratton MR: Loss of heterozygosity in sporadic breast cancer at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 72:1241, 1995
28. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670, 1995
29. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27, 1994
30. Nowell PC: The clonal evolution of tumor cell populations. Science 194:23, 1976
31. Shibata D, Scaeffer J, Li Z-H, Capella G, Perucho M: Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Inst 85:1058, 1993
32. Kern SE: Clonality: More than just a tumor-progression model. J Natl Cancer Inst 85:1020, 1993
33. Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque ATMS, Rozemblum E, Weinstein CL, Bittner M, Meltzer PS, Trent JM, Yeo CJ, Hruban RH, Kern SE: Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 92:5950, 1995